申请人:Hale Michael R.
公开号:US20090042973A1
公开(公告)日:2009-02-12
The present invention relates to a novel class of sulfonamides which are aspartyl protease inhibitors. In one embodiment, this invention relates to a novel class of HIV aspartyl protease inhibitors characterized by specific structural and physicochemical features. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting HIV-1 and HIV-2 protease activity and consequently, may be advantageously used as anti-viral agents against the HIV-1 and HIV-2 viruses. This invention also relates to methods for inhibiting the activity of HIV aspartyl protease using the compounds of this invention and methods for screening compounds for anti-HIV activity.
本发明涉及一种新型的磺胺类化合物,它们是天冬氨酸蛋白酶抑制剂。在一种实施方式中,本发明涉及一种新型的HIV天冬氨酸蛋白酶抑制剂,其具有特定的结构和物理化学特征。本发明还涉及包含这些化合物的制药组合物。本发明的化合物和制药组合物非常适合抑制HIV-1和HIV-2蛋白酶活性,因此可以作为抗HIV-1和HIV-2病毒的抗病毒剂得到优越的应用。本发明还涉及使用本发明的化合物抑制HIV天冬氨酸蛋白酶活性的方法以及筛选抗HIV活性化合物的方法。